$2.5 trillion.'That was the amount spent in the United States on health care in 2009.2 For that
year, this spending translated into 17.6 percent of gross domestic product, even though it …

A problem perennially facing scholars of both intellectual property and health law is the
need to appropriately incentivize the development of new pharmaceuticals. Although …

There is a widespread perception that drug prices in the US are much higher than they
should be, and that the problem is only getting worse. Critics argue that the pharmaceutical …

The push to lower pharmaceutical drug prices has taken a stronger foothold in legislative
and executive actions in recent years. With average prices rising continuously over the past …

Each year, physicians in the United States write more than three billion prescriptions, or
about twelve prescriptions per American.'In 2009 alone, the United States spent some $300 …

The makers of branded pharmaceuticals have devised numerous ways to extend patent
exclusivity for lucrative products in the United States. In June, the Supreme Court gave the …

In March of 2010, Congress enacted the Patient Protection and Affordable Care Act'-to which
I will refer simply as" the Act"-to cope with what Congress believed was a crisis in the $2.5 …

In today's fast-paced world where Americans crave a quick fix to their medical woes, it takes
more than advice on a healthy lifestyle to satisfy consumers. But along with cutting-edge …

In recent years, lowering the cost of prescription drugs has been a hot topic on Capitol Hill.
Many lives are saved and prolonged each year by prescription drugs. In recent years, new …